Don C. Rockey

30.5k total citations · 4 hit papers
462 papers, 20.0k citations indexed

About

Don C. Rockey is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Don C. Rockey has authored 462 papers receiving a total of 20.0k indexed citations (citations by other indexed papers that have themselves been cited), including 200 papers in Hepatology, 183 papers in Epidemiology and 151 papers in Surgery. Recurrent topics in Don C. Rockey's work include Liver Disease Diagnosis and Treatment (173 papers), Liver Disease and Transplantation (138 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (63 papers). Don C. Rockey is often cited by papers focused on Liver Disease Diagnosis and Treatment (173 papers), Liver Disease and Transplantation (138 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (63 papers). Don C. Rockey collaborates with scholars based in United States, United Kingdom and Canada. Don C. Rockey's co-authors include Scott L. Friedman, P. Darwin Bell, Joseph A. Hill, John P. Cello, Alastair D. Smith, Zachary Goodman, Rendon C. Nelson, Stephen H. Caldwell, Jean‐Ju Chung and Zengdun Shi and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Don C. Rockey

437 papers receiving 19.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liver biopsy†

2008 1.4k citations Don C. Rockey et al. Hepatology profile →
Fibrosis — A Common Pathway to Organ Injury and Failure

2015 1.0k citations Don C. Rockey et al. profile →
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis

2024 63 citations Don C. Rockey et al. Hepatology profile →
AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis

2024 44 citations Don C. Rockey et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Don C. Rockey United States	72	8.8k	8.3k	6.0k	2.7k	2.5k	462	20.0k
Siddharth Singh United States	72	4.5k 0.5×	11.1k 1.3×	6.2k 1.0×	2.0k 0.8×	1.9k 0.8×	412	20.9k
Tilman Sauerbruch Germany	74	7.8k 0.9×	7.5k 0.9×	6.0k 1.0×	1.8k 0.7×	2.9k 1.1×	525	18.6k
Oscar W. Cummings United States	62	4.7k 0.5×	11.3k 1.4×	5.8k 1.0×	3.0k 1.1×	3.6k 1.4×	200	19.6k
Frank Lammert Germany	65	5.3k 0.6×	6.6k 0.8×	5.4k 0.9×	1.9k 0.7×	3.8k 1.5×	514	15.3k
Kris V. Kowdley United States	86	14.5k 1.6×	20.1k 2.4×	5.6k 0.9×	3.2k 1.2×	2.9k 1.1×	451	29.4k
Rocío López United States	69	4.0k 0.5×	8.6k 1.0×	6.5k 1.1×	1.9k 0.7×	2.2k 0.9×	570	18.0k
Shou‐Dong Lee Taiwan	56	8.9k 1.0×	8.0k 1.0×	3.4k 0.6×	1.7k 0.6×	1.8k 0.7×	462	14.2k
Shiv Kumar Sarin India	75	15.8k 1.8×	15.0k 1.8×	7.3k 1.2×	1.9k 0.7×	783 0.3×	735	22.6k
Julián Panés Spain	84	2.2k 0.2×	11.2k 1.3×	8.5k 1.4×	2.8k 1.0×	2.7k 1.1×	590	26.0k
Patrick S. Kamath United States	85	23.6k 2.7×	22.4k 2.7×	13.3k 2.2×	2.3k 0.9×	1.2k 0.5×	423	34.2k

Countries citing papers authored by Don C. Rockey

Since Specialization

Citations

This map shows the geographic impact of Don C. Rockey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don C. Rockey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don C. Rockey more than expected).

Fields of papers citing papers by Don C. Rockey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don C. Rockey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don C. Rockey. The network helps show where Don C. Rockey may publish in the future.

Co-authorship network of co-authors of Don C. Rockey

This figure shows the co-authorship network connecting the top 25 collaborators of Don C. Rockey. A scholar is included among the top collaborators of Don C. Rockey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don C. Rockey. Don C. Rockey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rockey, Don C., Fredric D. Gordon, Paul J. Thuluvath, et al.. (2025). Terlipressin for Hepatorenal Syndrome in Patients With Early‐Stage Acute‐on‐Chronic Liver Failure. Liver International. 45(12). e70399–e70399. 3 indexed citations

Rockey, Don C., et al.. (2025). Risk scoring systems to predict in-hospital mortality in patients with cirrhosis admitted with acute upper gastrointestinal bleeding. Journal of Investigative Medicine. 74(3). 260–268.

Rhee, Kyu Y., Charles W. Emala, Emily J. Gallagher, et al.. (2025). Paving the physician-scientist career path: from grassroots gathering to national forum. JCI Insight. 10(7).

Rockey, Don C., et al.. (2024). Sa1596 HOW DOES THE “WEEKEND EFFECT” INFLUENCE OUTCOMES IN PATIENTS ADMITTED WITH DECOMPENSATED CIRRHOSIS? – NATIONAL INPATIENT SAMPLE STUDY. Gastroenterology. 166(5). S–1590.

Gallagher, Emily J., Paul R. Conlin, Barbara I. Kazmierczak, et al.. (2024). Is it time to reduce the length of postgraduate training for physician-scientists in internal medicine?. JCI Insight. 9(10). 4 indexed citations

Edelson, Jerome, et al.. (2024). Endoscopic ultrasound‐guided portal pressure gradient identifies patients with previously undiagnosed clinically significant portal hypertension. SHILAP Revista de lepidopterología. 3(2). 67–74. 2 indexed citations

Loomba, Rohit, Jeffrey Teckman, Veeral Ajmera, et al.. (2024). Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease. Alimentary Pharmacology & Therapeutics. 59(10). 1183–1195. 3 indexed citations

Khalifa, Ali & Don C. Rockey. (2023). Role of Endoscopy in the Diagnosis, Grading, and Treatment of Portal Hypertensive Gastropathy and Gastric Antral Vascular Ectasia. Gastrointestinal Endoscopy Clinics of North America. 34(2). 263–274. 2 indexed citations

Rockey, Don C., et al.. (2023). Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Alimentary Pharmacology & Therapeutics. 57(5). 454–463. 10 indexed citations

10.

Williams, Christopher S., Emily J. Gallagher, Don C. Rockey, et al.. (2023). Structural insights into the career path between pre- and postgraduate physician-scientist training programs. eLife. 12. 2 indexed citations

11.

Gallagher, Emily J., Don C. Rockey, Christopher D. Kontos, et al.. (2022). Pearls of wisdom for aspiring physician-scientist residency applicants and program directors. JCI Insight. 7(6). 5 indexed citations

12.

Rockey, Don C., et al.. (2020). Non‐selective beta‐blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection. Alimentary Pharmacology & Therapeutics. 53(3). 418–425. 10 indexed citations

13.

Edelson, Jerome, et al.. (2020). Improving haemodynamics in acute gastrointestinal bleeding: Ketamine for endoscopic sedation in active gastrointestinal bleeding in critically Ill patients. 2(6). 288–294. 1 indexed citations

14.

Park, Ki-Hoon, Zhiwei Ye, Jie Zhang, et al.. (2019). 3-ketodihydrosphingosine reductase mutation induces steatosis and hepatic injury in zebrafish. Scientific Reports. 9(1). 1138–1138. 24 indexed citations

15.

Abraldeṣ, Juan G., Jonel Trebicka, Naga Chalasani, et al.. (2018). Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension. Hepatology. 69(3). 1287–1299. 35 indexed citations

16.

Gupta, Samir, Liyue Tong, James E. Allison, et al.. (2009). Screening for Colorectal Cancer in a Safety-Net Health Care System: Access to Care Is Critical and Has Implications for Screening Policy. Cancer Epidemiology Biomarkers & Prevention. 18(9). 2373–2379. 26 indexed citations

17.

Suzuki, Kenji, Don C. Rockey, & Abraham H. Dachman. (2009). CT colonography: Advanced computer‐aided detection scheme utilizing MTANNs for detection of “missed” polyps in a multicenter clinical trial. Medical Physics. 37(1). 12–21. 30 indexed citations

18.

Rockey, Don C.. (2008). Computed tomographic colonography. Current Opinion in Gastroenterology. 25(1). 55–58. 3 indexed citations

19.

Rockey, Don C.. (2005). Proton pump inhibitors in acute peptic ulcer bleeding. Gastroenterology. 129(2). 756–757. 3 indexed citations

20.

Rockey, Don C. & Richard A. Weisiger. (1996). Endothelin Induced Contractility of Stellate Cells From Normal and Cirrhotic Rat Liver: Implications for Regulation of Portal Pressure and Resistance. Hepatology. 24(1). 233–240. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact